Novartis Investigative Site
Cardiff, Wales, United Kingdom
NCT Number: NCT00452270
The aim of this study is to characterize the time profile of the decongestant properties of xylometazoline and to investigate its effect on sleep, general well-being and smell/taste.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Cardiff, Wales, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other protocol-defined inclusion/exclusion criteria may apply.
Novartis
Industry
A Double-Blind, Randomized, Parallel Group, Placebo Controlled Study, Evaluating the Decongestant Effect, Time to Onset, Duration of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06724185
Common Cold, Immunity
Taichung, Taiwan
View Trial DetailsNCT00448981
Common Cold, Infections
New York, United States
View Trial DetailsNCT06716645
Common Cold, Cough
New York, United States
View Trial DetailsNCT06278324
Acute Respiratory Tract Infection, COVID-19
Dijon, Burgundy, France
View Trial Details